These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7025545)

  • 81. Clinical response to metyrapone as indicated by measurement of mineralocorticoids and glucocorticoids in normal children.
    Sonino N; Chow D; Levine LS; New MI
    Clin Endocrinol (Oxf); 1981 Jan; 14(1):31-9. PubMed ID: 7226574
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism.
    Lefebvre H; Cartier D; Duparc C; Contesse V; Lihrmann I; Delarue C; Vaudry H; Fischmeister R; Kuhn JM
    Endocr Res; 2000 Nov; 26(4):583-7. PubMed ID: 11196433
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Glucocorticoid-suppressible hyperaldosteronism: effects of crossover site and parental origin of chimaeric gene on phenotypic expression.
    Jamieson A; Slutsker L; Inglis GC; Fraser R; White PC; Connell JM
    Clin Sci (Lond); 1995 May; 88(5):563-70. PubMed ID: 7614815
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Regulation of aldosterone receptors in hypertension.
    Armanini D; Zennaro CM; Martella L; Pratesi C; Scali M; Zampollo V
    Steroids; 1993 Dec; 58(12):611-3. PubMed ID: 8116017
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Monogenic forms of low-renin hypertension: clinical and molecular insights.
    Khandelwal P; Deinum J
    Pediatr Nephrol; 2022 Jul; 37(7):1495-1509. PubMed ID: 34414500
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Chronic mineralocorticoid excess and cardiovascular remodeling.
    Weber KT; Sun Y; Campbell SE; Slight SH; Ganjam VK; Griffing GT; Swinfard RW; Diaz-Arias AA
    Steroids; 1995 Jan; 60(1):125-32. PubMed ID: 7792797
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Dexamethasone-suppressible hyperaldosteronism: studies on overproduction of 18-hydroxycortisol in three affected family members.
    Davis JR; Burt D; Corrie JE; Edwards CR; Sheppard MC
    Clin Endocrinol (Oxf); 1988 Sep; 29(3):297-308. PubMed ID: 3251669
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Evidence for an unidentified, adrenocorticotrophic hormone-dependent mineralocorticoid maintaining hypertension in young women with hypoaldosteronism.
    Hoefnagels WH; Drayer JI; Hofman JA; Smals AG; Benraad TJ; Kloppenborg PW
    Clin Sci Mol Med Suppl; 1978 Dec; 4():271s-274s. PubMed ID: 282066
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Radioimmunoassay of serum deoxycorticosterone: normal values and changes of serum deoxycorticosterone after adrenal stimulation.
    Schöneshöfer M; Oelkers W; Harendt H
    Z Klin Chem Klin Biochem; 1975 Apr; 13(4):143-7. PubMed ID: 168695
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effects of various adrenal inhibitors in low-renin essential hypertension.
    Liddle GW; Hollifield JW; Slaton PE; Wilson HM
    J Steroid Biochem; 1976; 7(11-12):937-40. PubMed ID: 799736
    [No Abstract]   [Full Text] [Related]  

  • 91. Aldosterone and Treatment-Resistant Hypertension.
    Leopold JA; Ingelfinger JR
    N Engl J Med; 2023 Feb; 388(5):464-467. PubMed ID: 36724334
    [No Abstract]   [Full Text] [Related]  

  • 92. Long-term treatment of mineralocorticoid excess syndromes.
    Mantero F; Opocher G; Rocco S; Carpenè G; Armanini D
    Steroids; 1995 Jan; 60(1):81-6. PubMed ID: 7792822
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Glucocorticoid-suppressible hyperaldosteronism: a paradigm of arrested adrenal zonation?
    Ganguly A
    Clin Sci (Lond); 1991 Jan; 80(1):1-7. PubMed ID: 1846785
    [No Abstract]   [Full Text] [Related]  

  • 94. The role of 11-deoxycorticosterone in human hypertension.
    Tan SY; Noth RH; Mulrow PJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():311s-314s. PubMed ID: 1071634
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Aldosterone and in vivo mineralocorticoid activity in normotensive and hypertensive man.
    Skrabal F
    J R Soc Med; 1979 Apr; 72(4):252-9. PubMed ID: 233248
    [No Abstract]   [Full Text] [Related]  

  • 96. Genetic screening of hypertensive patients with aldosterone hypersecretion under conditions of stress.
    Mourtzi N; Sertedaki A; Markou A; Piaditis GP; Katsanis N; Traeger-Synodinos J; Tsigos C; Charmandari E
    Hormones (Athens); 2022 Dec; 21(4):525-536. PubMed ID: 36044182
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Primary hyperaldosteronism.
    Levi M
    Am J Med Sci; 1990 Sep; 300(3):189-202. PubMed ID: 2240013
    [No Abstract]   [Full Text] [Related]  

  • 98. 19-Noraldosterone, a new mineralocorticoid.
    Takeda Y; Miyamori I
    Endocr J; 1994 Oct; 41(5):483-9. PubMed ID: 7889107
    [No Abstract]   [Full Text] [Related]  

  • 99. Recent advances in human steroid metabolism.
    Hellman L; Bradlow HL; Zumoff B
    Adv Clin Chem; 1970; 13():1-35. PubMed ID: 4319641
    [No Abstract]   [Full Text] [Related]  

  • 100. Control of hyperaldosteronism by ketoconazole.
    Benito P; Corpas MS; Quesada JM; Jiménez JA
    Drug Intell Clin Pharm; 1987 Sep; 21(9):752. PubMed ID: 3652938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.